IQVIA Holdings
IQVIA Holdings Inc is an American provider of advanced analytics, clinical research services, and healthcare technology solutions to the life sciences industry. The company operates through three main business segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Its primary revenue drivers include contract research services for clinical trials, health data licensing, and proprietary software subscriptions for commercial analytics. The end markets served encompass global pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers. IQVIA holds a dominant global market position in clinical development services and healthcare data analytics, formed via the merger of Quintiles and IMS Health. The company is headquartered in Durham, North Carolina, and its common stock is listed on the New York Stock Exchange under the ticker symbol IQV.
68 of the funds FundTelligence covers report a position in IQVIA Holdings.
- Legal name
- IQVIA Holdings Inc.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 68
Funds holding IQVIA Holdings
- Lyrical U.S. Value Equity Strategy — Lyrical · 4.3 % (largest positions only, October 2026)
- Nordea Fremtid — Nordea Funds · 3.63 % (full portfolio disclosed, September 2026)
- Fondsfinans Global Helse — Fondsfinans · 3.23 % (full portfolio disclosed, October 2026)
- BGF Next Generation Health Care Fund — BlackRock · 2.28 % (largest positions only, January 2026)
- SEB Läkemedelsfond — SEB · 1.9 % (full portfolio disclosed, June 2026)
- GS Multi-Manager Dynamic World Equity Portfolio — Goldman Sachs · 1.8 % (largest positions only, October 2026)
- Pareto ESG Global Corporate Bond — Pareto · 1.74 % (full portfolio disclosed, June 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 1.71 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 68 funds holding it.